AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/305

Authors: RUFFER U EISENBARTH M GLASER B LENZEN S TRALLS P DIEHL V FLECHTNER H
Citation: U. Ruffer et al., ASSESSMENT OF THE LIFE SITUATION AND THE QUALITY-OF-LIFE IN LONG-TERMSURVIVORS OF HODGKINS-DISEASE, Quality of life research, 6(7-8), 1997, pp. 323-323

Authors: JOX A KORNACKER M WOLF J DIEHL V
Citation: A. Jox et al., THE BIOLOGY OF HODGKINS-DISEASE, European journal of cancer, 33, 1997, pp. 995-995

Authors: BARTH S MATTHEY B SCHON G DIEHL V ENGERT A
Citation: S. Barth et al., DEVELOPMENT OF A NEW RECOMBINANT ANTI-CD30 IMMUNOTOXIN (CD30L-ETA) FOR THE TREATMENT OF HODGKINS LYMPHOMA, European journal of cancer, 33, 1997, pp. 39-39

Authors: MATTHEY B ENGERT A DIEHL V BARTH S
Citation: B. Matthey et al., PBM1.1, A NEW PET-BASED VECTOR FOR HIGH-EFFICIENCY EXPRESSION OF ETA FUSION TOXINS, European journal of cancer, 33, 1997, pp. 129-129

Authors: WOLF J SCHELLONG G DIEHL V
Citation: J. Wolf et al., BREAST-CANCER FOLLOWING TREATMENT OF HODGKINS-DISEASE - MORE REASONS FOR LESS RADIOTHERAPY, European journal of cancer, 33(14), 1997, pp. 2293-2294

Authors: THIELE J ZIRBES TK LORENZEN J KVASNICKA HM SCHOLZ S ERDMANN A FLUCKE U DIEHL V FISCHER R
Citation: J. Thiele et al., HEMATOPOIETIC TURNOVER INDEX IN REACTIVE AND NEOPLASTIC BONE-MARROW LESIONS - QUANTIFICATION BY APOPTOSIS AND PCNA LABELING, Annals of hematology, 75(1-2), 1997, pp. 33-39

Authors: HEINDEL W DEROCHEMONT RD KUGEL H ERNST S TESCH H DIEHL V LACKNER K
Citation: W. Heindel et al., P-31-MR SPECTROSCOPY OF THE HUMAN LIVER - SPECTRAL HINTS ON HEPATIC LYMPHOMA INFILTRATION, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 167(1), 1997, pp. 62-70

Authors: DIEHL V SIEBER M RUFFER U LATHAN B HASENCLEVER D PFREUNDSCHUH M LOEFFLER M LIEBERZ D KOCH P ADLER M TESCH H
Citation: V. Diehl et al., BEACOPP - AN INTENSIFIED CHEMOTHERAPY REGIMEN IN ADVANCED HODGKINS-DISEASE, Annals of oncology, 8(2), 1997, pp. 143-148

Authors: JOX A ROHEN C BELGE G BARTNITZKE S PAWLITA M DIEHL V BULLERDIEK J WOLF J
Citation: A. Jox et al., INTEGRATION OF EPSTEIN-BARR-VIRUS IN BURKITTS-LYMPHOMA CELLS LEADS TOA REGION OF ENHANCED CHROMOSOME INSTABILITY, Annals of oncology, 8, 1997, pp. 131-135

Authors: WINKLER U BARTH S SCHNELL R DIEHL V ENGERT A
Citation: U. Winkler et al., THE EMERGING ROLE OF IMMUNOTOXINS IN LEUKEMIA AND LYMPHOMA, Annals of oncology, 8, 1997, pp. 139-146

Authors: HUBEL K TESCH H KROGER B SCHNELL R BORCHMANN P DIEHL V ENGERT A
Citation: K. Hubel et al., A PHASE I II STUDY OF IDARUBICIN, DEXAMETHASONE AND INTERFERON-ALPHA (I-DEXA) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE-MYELOMA/, Leukemia, 11, 1997, pp. 47-51

Authors: LOEFFLER M DIEHL V PFREUNDSCHUH M RUHL U HASENCLEVER D NISTERSBACKES H SIEBER M TESCH H FRANKLIN J GEILEN W BARTELS H CARTONI C DOLKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HILLER E HINKELBEIN H HINTERBERGER W KIRCHNER H KOCH P KRUGER B KURTEN H KUTZNER K LOOS U MENDE W MULLER H OERTEL W PETSCH S PFAB R PFLUGER H ROHLOFF R SAUER R SCHALK K SCHICK HD SCHOPPE W SZEPESI S TEICHMANN J WORST P FISCHER R GEORGII A HUBNER K SCHWARZE EW
Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287

Authors: DREES C GROND M SZELIES B DIETLEIN M SALZBERGER B DIEHL V HEISS WD
Citation: C. Drees et al., POLYNEUROPATHY IN MONOCLONAL GAMMOPATHY O F UNDETERMINED SIGNIFICANCE(MGUS) - INITIAL MANIFESTATION OF A LYMPHOMA, Medizinische Klinik, 92(2), 1997, pp. 112-116

Authors: MANZKE O TITZER S TESCH H DIEHL V BOHLEN H
Citation: O. Manzke et al., CD3-X-CD19 BISPECIFIC ANTIBODIES AND CD28 COSTIMULATION FOR LOCOREGIONAL TREATMENT OF LOW-MALIGNANCY NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 198-202

Authors: FRANKE H ENGEL C LOEFFLER M DIEHL V SCHMITZ S
Citation: H. Franke et al., DOSE INTENSIFICATION OF CHEMOTHERAPY - AN ESTIMATION OF HEMATOLOGICALTOXICITY AND THE EFFECT OF DIFFERENT G-CSF ADMINISTRATION BY MODEL SIMULATION, Experimental hematology, 25(8), 1997, pp. 159-159

Authors: SCHEID C HINRICHS R WINTER S SCHULZ A DIEHL V WICKRAMANAYAKE PD
Citation: C. Scheid et al., T-CELL SUBPOPULATIONS AND NK FUNCTION AFTER AUTOLOGOUS PERIPHERAL PROGENITOR-CELL TRANSPLANTATION - PREFERENTIAL RECOVERY OF CELLS WITH CYTOTOXIC POTENTIAL, Experimental hematology, 25(8), 1997, pp. 284-284

Authors: WINKLER U RIEDER H MARZ W VOLIOTIS D FRANZEN C SCHMITZ S REHDER H DIEHL V ENGERT A
Citation: U. Winkler et al., ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL CELL-LINE FROM A PATIENT WITH AN ACUTE MYELOID-LEUKEMIA, FAB M6, WITH COMPLEX CHROMOSOMAL-ABERRATIONS, Experimental hematology, 25(8), 1997, pp. 446-446

Authors: JOX A WOLF J DIEHL V
Citation: A. Jox et al., HODGKINS-DISEASE BIOLOGY - RECENT ADVANCES, Hematological oncology, 15(4), 1997, pp. 165-171

Authors: HOMBACH A MATHAS S JENSEN M TILLMANN T MENGES M DIEHL V KRUIS W POHL C
Citation: A. Hombach et al., ACTIVATION OF RESTING T-CELLS AGAINST THE CA-72-4 TUMOR-ANTIGEN WITH AN ANTI-CD3 CA-72-4 BISPECIFIC ANTIBODY IN COMBINATION WITH A COSTIMULATORY ANTI-CD28 ANTIBODY/, Anticancer research, 17(3C), 1997, pp. 2025-2032

Authors: REISER M FATKENHEUER G DIEHL V
Citation: M. Reiser et al., PARADOXICAL EXPANSION OF INTRACRANIAL TUBERCULOMAS DURING CHEMOTHERAPY, The Journal of infection, 35(1), 1997, pp. 88-90

Authors: SCHMITZ N DIEHL V
Citation: N. Schmitz et V. Diehl, CARMUSTINE AND THE LUNGS, Lancet, 349(9067), 1997, pp. 1712-1713

Authors: FATKENHEUER G ARNOLD G STEFFEN HM FRANZEN C SCHRAPPE M DIEHL V SALZBERGER B
Citation: G. Fatkenheuer et al., INVASIVE AMEBIASIS IN 2 PATIENTS WITH AIDS AND CYTOMEGALOVIRUS COLITIS, Journal of clinical microbiology, 35(8), 1997, pp. 2168-2169

Authors: FRANZEN C ALTFELD M HEGENER P HARTMANN P ARENDT G JABLONOWSKI H ROCKSTROH J DIEHL V SALZBERGER B FATKENHEUER G
Citation: C. Franzen et al., LIMITED VALUE OF PCR FOR DETECTION OF TOXOPLASMA-GONDII IN BLOOD FROMHUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Journal of clinical microbiology, 35(10), 1997, pp. 2639-2641

Authors: JOX A ZANDER T DIEHL V WOLF J
Citation: A. Jox et al., CLONAL RELAPSE IN HODGKINS-DISEASE, The New England journal of medicine, 337(7), 1997, pp. 499-499

Authors: THIELE J ZIRBES TK LORENZEN J KVASNICKA HM DRESBACH S MANICH B LEDER LD NIEDERLE N DIEHL V FISCHER R
Citation: J. Thiele et al., APOPTOSIS AND PROLIFERATION (PCNA LABELING) IN CML - A COMPARATIVE IMMUNOHISTOLOGICAL STUDY ON BONE-MARROW BIOPSIES FOLLOWING INTERFERON AND BUSULFAN THERAPY, Journal of pathology, 181(3), 1997, pp. 316-322
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>